No Picture
News

Ardelyx and Kyowa Kirin Highlight New Data Supporting the Clinical Safety and Efficacy of First-In-Class, Phosphate Absorption Inhibitor Tenapanor at ASN’s Kidney Week 2020

–Data presented across five posters continue to support the foundational role tenapanorcould play in the treatment of hyperphosphatemia—-Exhibitor Spotlight presentation highlights advances in the science of phosphate absorption–

FREMONT, C… […]

No Picture
News

BioMarin to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5 at 4:30pm ET

SAN RAFAEL, Calif., Oct. 22, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, November… […]

No Picture
News

Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine

EMERYVILLE, Calif., Oct. 22, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients… […]

No Picture
News

Natera to Present New Data at ASN Kidney Week 2020 Showing Clinical Differentiation of the Prospera(TM) Test

Represents largest dd-cfDNA retransplant study to date and demonstrates clinical value of proprietary background cfDNA technology

SAN CARLOS, Calif., Oct. 21, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free … […]

No Picture
News

Microvi Expands Reach to Areas Hit Hardest with Nitrate Pollution in Central Valley of California

HAYWARD, Calif., Oct. 20, 2020 /PRNewswire/ — Microvi, in partnership with the City of Modesto and global nonprofit climate-tech accelerator Elemental Excelerator, will install a Microvi MNE nitrate treatment system in Modesto, California. Schedule… […]

No Picture
News

Olema Oncology to Present Preclinical Data on OP-1250, Lead Program in Breast Cancer, at ENA 2020

SAN FRANCISCO, Oct. 20, 2020 /PRNewswire/ — Olema Oncology, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced it will present preclin… […]